Skip to content

Emotional modulation of attentional selection: A transcranial magnetic stimulation study

Emotional modulation of attentional selection: A transcranial magnetic stimulation study - emotional attention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40338
Enrollment
24
Registered
2013-09-03
Start date
2014-05-09
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fundamenteel onderzoek bij gezonde proefpersonen NA

Interventions

None listed

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - aged between 18 and 35 - normal or corrected to normal vision - not color blind - normal hearing - right- handedness - non-smoking - females taking contraceptives

Exclusion criteria

Exclusion criteria: Exclusion criteria for participation include metal in cranium, use of psychotropic drugs, including cannabis, XTC,amphetamines and cocaine, epilepsy or family history of epilepsy, history of closed-head injury, history of neurological or psychiatric disorders, medication use (i.e., benzodiazepines, antidepressants and neuroleptica), cardiac pacemaker, pregnancy and electronic hearing devices.

Design outcomes

Primary

MeasureTime frame
A repeated measures ANOVA with TMS (sham TMS, left rTMS, right rTMS) and distractor (CS+, CS-) as factors will be carried out on difference RT score and error rates. If appropriate, planned comparisons between the conditions will be performed. The alpha level of significance will be set at 0.05 (two-tailed) throughout.

Secondary

MeasureTime frame
Pearson*s correlation coefficient will determine the correlation between the level of state anxiety as measured by the VAS and attentional capture by threatening distractors as indexed by the difference RT score.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)